Trial Profile
Pivotal study of Teleukin, in combination with cytarabine for patients with Acute Myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs F16 IL2 fusion protein (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 12 Sep 2016 New trial record